3D-CRT联合卡培他滨治疗晚期胰腺癌近期疗效观察
二级参考文献21
-
1张蓓,朱立勤.乳腺癌药物治疗的研究进展[J].中国药物与临床,2004,4(8):616-619. 被引量：5
-
2Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6 000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil),and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group [ J ] . Cancer, 1981, 48(8):1705-1710.
-
3Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas:comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone [ J ] . J Natl Cancer Inst, 1988, 80(10): 751-755.
-
4Burris HA 3rd, Moore M J, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial [ J ] . J Clin Oncol, 1997, 15(6): 2403-2413.
-
5Chauffert B, Mornex F, Bonnetain F, et al. Phase Ⅲ trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study [ J ] . Ann Oncol, 2008,19(9): 1592-1599.
-
6Loehrer PJ, Powell ME, Cardenes HR, et al. A randomized phase Ⅲ study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 [ J ]. J Clin Oncol, 2008, 26(suppl): abstr 4506.
-
7Saif MW, Black G, Roy S, et al. Phase study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase [ J ]. Cancer J, 2007, 13(4): 247-256.
-
8Lawrence TS, Chang EY, Hahn TM, et al. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine [ J ] . Int J Radiat Oncol Biol Phys, 1996, 34(4): 867-872.
-
9Small W Jr, Berlin J, Freedman GM, et al. Full-dose gemeitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase Ⅱ trial [ J ]. J Clin Oncol, 2008, 26(6): 942-947.
-
10Hong SP, Park JY, Jeon TJ, et al. Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer [ J ] . Br J Cancer, 2008, 98(5): 881-887.
共引文献13
-
1余少培,杨静.吉西他滨联合免疫效应细胞对胰腺癌细胞BxPC-3生长的抑制[J].世界华人消化杂志,2010,18(20):2095-2101.
-
2黄琰菁,桂玲,于世英.化学治疗所致肝检查异常4种治疗方案的最小成本分析[J].医药导报,2010,29(11):1503-1505. 被引量：2
-
3李晓姝,郭晓钟,任丽楠,邹德莉.胰腺癌207例临床病理特征分析[J].实用癌症杂志,2010,25(6):638-641. 被引量：7
-
4代素梅,房芳,冯万芹,陈红,王海波,刘华群.三维适形放疗、同步化疗加热疗治疗中晚期胰腺癌疗效观察[J].山东医药,2010,50(49):96-97. 被引量：4
-
5韩冰,赵爱光,赵刚,杨金坤,杨金祖,高峰,顾缨,徐燕,孙姗姗,吕仙梅.健脾为基础中医药治疗对中晚期胰腺癌生存期影响的研究[J].中国肿瘤,2011,20(3):213-218. 被引量：13
-
6吴晨彬,吴君心,徐鹭英,陈娜,程文芳,王立峰.胃作为放疗危及器官的扩边研究[J].肿瘤学杂志,2012,18(6):441-443.
-
7傅成斌,黄鹤光,陈燕昌,陆逢春.胰腺癌预后的多因素分析[J].国际外科学杂志,2013,40(5):303-306. 被引量：6
-
8李爽,李贵新,邓军吉,王文浩,崔传水,陈伟,刘锦,马长庚.胰腺癌三种精确放疗计划剂量学比较与分析[J].中华肿瘤防治杂志,2013,20(20):1604-1606. 被引量：5
-
9王慧,陈雷华.胰腺癌患者行高强度聚焦超声治疗的观察与护理[J].上海护理,2014,14(3):57-59. 被引量：1
-
10欧双艳.晚期胰腺癌的化疗疗效观察[J].中国卫生产业,2014,11(19):151-152.
-
1刘家盛,赵端仪,黄汉涛,钱崇宽,张蓓,魏莱.残胃癌的临床研究[J].武警医学院学报,2007,16(4):400-401.
-
2苏向前,李子禹,步召德,张霁,王怡,季加孚.残胃癌的外科治疗[J].中国实用外科杂志,2004,24(7):406-408. 被引量：37
-
3李宏江,赵扬冰,敬静,朱精强,李志宇.Ⅳ期乳腺癌的外科治疗及TNM分期探讨[J].中国普外基础与临床杂志,2001,8(5):315-316. 被引量：4
-
4李宏江,朱精强,赵扬冰,敬静,李志宇.Ⅲ、Ⅳ期乳腺癌的外科治疗[J].临床外科杂志,2000,8(5):268-269. 被引量：2
-
5曾勇,姚辉华,严律南,李波,文天夫.高龄胰腺癌病人的外科处理(附36例报道)[J].中华肝胆外科杂志,2004,10(4):277-278.
-
6罗恩,王洪林.肝门部胆管癌的根治性外科治疗与姑息性治疗效果比较[J].成都医学院学报,2011,6(1):55-57. 被引量：2
-
7胡逸林,金炜东,曹庭加,王再兴.残胃癌39例诊治及预后分析[J].蚌埠医学院学报,2009,34(7):594-595. 被引量：2
-
8曹秀峰,李苏卿.微小RNA在食管癌诊断预后及治疗中的作用[J].中华肿瘤杂志,2011,33(3):161-164. 被引量：11
-
9徐杰.晚期胰腺癌17例高强度聚焦超声治疗的体会[J].基层医学论坛,2009,13(31):992-993.
-
10袁宏银,解云涛,王坤.直肠癌术后局部复发原因探讨[J].肿瘤防治研究,1996,23(5):314-316. 被引量：3
